11
12
Smolders, E. J., Smit, C., de Kanter, C. T. M. M., Dofferhoff, A. S. M., Arends, J. E., Brinkman, K., Rijnders, B., van der Valk, M., Reiss, P., Burger, D. M.
Veröffentlicht in: ATHENA National Observational HIV Cohort , Smolders , E J , Smit , C , de Kanter , C T M M , Dofferhoff , A S M , Arends , J E , Brinkman , K , Rijnders , B , van der Valk , M , Reiss , P & Burger , D M 2018 , ' Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients : adequate but not perfect ' , HIV Medicine , vol. 19 , no. 3 , pp. 216-226 . https://doi.org/10.1111/hiv.12570;
2018
Veröffentlicht in: ATHENA National Observational HIV Cohort , Smolders , E J , Smit , C , de Kanter , C T M M , Dofferhoff , A S M , Arends , J E , Brinkman , K , Rijnders , B , van der Valk , M , Reiss , P & Burger , D M 2018 , ' Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients : adequate but not perfect ' , HIV Medicine , vol. 19 , no. 3 , pp. 216-226 . https://doi.org/10.1111/hiv.12570;
2018
13
van Dijk, Marleen, Brakenhoff, Sylvia M., Isfordink, Cas J., Cheng, Wei-Han, Blokzijl, Hans, Boland, Greet, Dofferhoff, Anthonius S. M., van Hoek, Bart, van Nieuwkoop, Cees, Sonneveld, Milan J., van der Valk, Marc, Drenth, Joost P. H., de Knegt, Robert J.
Veröffentlicht in: van Dijk , M , Brakenhoff , S M , Isfordink , C J , Cheng , W-H , Blokzijl , H , Boland , G , Dofferhoff , A S M , van Hoek , B , van Nieuwkoop , C , Sonneveld , M J , van der Valk , M , Drenth , J P H & de Knegt , R J 2021 , ' The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 ' , Journal of Clinical Medicine , vol. 10 , no. 19 , 4562 . https://doi.org/10.3390/jcm10194562;
2021
Veröffentlicht in: van Dijk , M , Brakenhoff , S M , Isfordink , C J , Cheng , W-H , Blokzijl , H , Boland , G , Dofferhoff , A S M , van Hoek , B , van Nieuwkoop , C , Sonneveld , M J , van der Valk , M , Drenth , J P H & de Knegt , R J 2021 , ' The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 ' , Journal of Clinical Medicine , vol. 10 , no. 19 , 4562 . https://doi.org/10.3390/jcm10194562;
2021
14
Bielen, Rob, Van Vlierberghe, Hans, Bourgeois, Stefan, Moreno, Christophe, Vanwollegem, Thomas, Verlinden, Wim, Mulkay, Jean-Pierre, Decaestecker, Jochen, Cool, Mike, de Galocsy, Chantal, Van Overbeke, Lode, Janssens, Filip, Van Steenkiste, Christophe, D'heygere, Francois, Cools, Wilfried, Nevens, Frederik, Robaeys, Geert
2016
2016
15
16
Ihsan N. Zulkipli, Rajan Rajabalaya, Adi Idris, Nurul Atiqah Sulaiman, Sheba R. David
Veröffentlicht in: Pharmaceutical Biology, Vol 55, Iss 1, Pp 1093-1113 (2017);
2017
Veröffentlicht in: Pharmaceutical Biology, Vol 55, Iss 1, Pp 1093-1113 (2017);
2017
17
18
19
Postma, Maarten J., Novak, Annoesjka, Scheijbeler, Huib W. K. F. H., Gyldmark, Marlene, van Genugten, Marianne L. L., Wilschut, Jan C.
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
20